Now Available: Sleep Aids in Italy


Recently published research from Euromonitor International, "Sleep Aids in Italy", is now available at Fast Market Research



[ClickPress, Mon Jan 11 2016] Towards the end of the review period, sales of sleep aids benefited from increasing levels of stress among Italian consumers. Although the Italian economy performed better in 2015, many Italians remained concerned about numerous issues, not least the adverse economic situation in the country. According to Assosalute, The National Association of Self-medication, eight out of ten Italians suffer from chronic stress, with 29% stressed about economic issues, 23% stressed about work and study, 17% stressed about the general economic and social situation in the country, 16 stressed about everyday problems, 10% stressed about health issues, 15% stressed about family issues and 8% stressed about relationship issues. Stress is also affecting Italians in terms of sleep problems, with some 12 million people regularly suffering from, or at risk of suffering from, insomnia. The proportion of Italians with insomnia issues increases to 12% during the period after the switch to daylight savings time in spring and this often continues throughout the summer due to the high temperatures experienced in Italy during summer months.

Full Report Details at
- http://www.fastmr.com/prod/1097888_sleep_aids_italy.aspx?afid=301

Competitive Landscape

Laborest Italia continued to lead calming and sleeping in Italy in 2015 with a value share of 8% thanks to its Pineal and Fisioreve brands. It is followed by Aboca with a 6% value share. Its main brand is Sedivitax, which is based on passiflora, chamomile and melissa. Aboca is the leader within vitamins and dietary supplements in Italy and the company continues to benefit from having been one of the first manufacturers specialising in naturally-positioned consumer health products. Other key brands within sleep aids in Italy include Armonia by Nathura SpA and Valdispert by Vemedia Pharma Srl.

Industry Prospects

Over the forecast period, sleep aids is expected to continue benefiting from the high levels of stress and insomnia among the Italian population, which are likely to subsist throughout the forecast period. As a result, value sales in sleep aids are expected to increase at a CAGR of 2% at 2015 constant prices, which is set to be in line with the 2% value CAGR recorded in the category over the review period. Italian consumers are expected to look especially for naturally positioned sleep aids and products offered in convenient packaging and delivery formats that can be taken on-the-go.

Report Overview

Discover the latest market trends and uncover sources of future market growth for the Sleep Aids industry in Italy with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Sleep Aids in Denmark
- Sleep Aids in Bulgaria
- Sleep Aids in Japan
- Sleep Aids in Greece
- Sleep Aids in Austria

Company: Fast Market Research, Inc.


Contact Name: Bill Thompson

Contact Email: press@fastmr.com

Contact Phone: 1-413-485-7001

>>Visit website